Wearable ultrasonic device for patient self-administered treatment of inflammation
Ended Definitive Contract Awarded Last action
- Contract number
- HR001124C0396
- Awardee
-
The Ultran Group, Inc. UEI JJWJS5MHTG87
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Obligated
- $2,999,629
Award facts
- Contract value 100% obligated
- $2,999,629.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- State College, PA, USA
- Research
- SBIR Program Phase II Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,199,816 | |
| Original award | $1,799,813 |
About this award
The Defense Advanced Research Projects Agency (DARPA) awarded The Ultran Group, Inc., a small business specializing in ultrasonic transducers and systems, a $3.0 million firm fixed price contract on February 15, 2024, for the development of a wearable ultrasonic device designed for patient self-administered treatment of inflammation. This Small Business Innovation Research (SBIR) Program Phase II action carries a total small business set-aside designation and is scheduled for completion by August 30, 2025, with performance to be conducted in State College, Pennsylvania. The contract represents DARPA's continued investment in innovative medical technologies that leverage ultrasonic principles for therapeutic applications, building on the agency's broader mission to develop transformative defense and dual-use technologies.
The Ultran Group has demonstrated sustained expertise in developing advanced ultrasound technologies for federal applications, with this award following a previous DARPA SBIR Phase II contract in 2019 valued at over $6.1 million for wearable ultrasound imaging and modulation capabilities. The company's track record in the federal contracting landscape, including an active Other Transaction IDV with the Department of the Army for chemical and biological defense research and development services, underscores its established role as a specialized provider of ultrasonic solutions to the U.S. government. As a small business registered to receive federal awards since 2001, The Ultran Group continues to position itself as a key innovator at the intersection of medical device development and defense research priorities.
Quick answers
Who was awarded contract HR001124C0396?
HR001124C0396 was awarded to The Ultran Group, Inc. by Defense Advanced Research Projects Agency (Department of Defense) on February 15, 2024.
How much is contract HR001124C0396 worth?
The government has obligated $2,999,629 on HR001124C0396.
Was contract HR001124C0396 competed?
The extent of competition for HR001124C0396 was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award